Mission

NEUROINNOVATECH’s mission is to develop cutting-edge novel drugs to improve treatment outcomes for CNS disorders, fostering better physical health, cognition, and social functioning for patients.

Vision

NEUROINNOVATECH’s vision is to transform CNS disorder treatments, enabling safer, more effective and efficient treatment options for patients suffering from various types of CNS disorders. To this end, NEUROINNOVATECH will adopt an aggressive license strategy.

Background

  • Many forms of mental disorders exist, each presenting unique challenges and symptoms.
  • Approximately 1 billion people experience neurological disorders such as Alzheimer’s, Parkinson’s, strokes, multiple sclerosis, epilepsy, migraine, brain injuries, and neuroinfections.
  • One in every 8 individuals worldwide struggle with a mental disorder.
  • Mental disorders involve significant disturbances in cognition, emotional control, or behavior.

 

What is CNS?
Central nervous system (CNS) disorders encompass a broad range of conditions that affect the brain and spinal cord, from neurodegenerative conditions, to mental health disorders, to neurological conditions affecting movement, cognition, and sensation. Each disorder has its own unique symptoms, causes, and treatments, and may require different approaches for diagnosis and management.

NEUROINNOVATECH’s Target Indications
NEUROINNOVATECH has identified the following 5 CNS disorders as the company’s key target focus disorders:

Obsessive-Compulsive Disorder (OCD) (partial responders):

OCD is a mental health disorder characterized by persistent, unwanted thoughts (obsessions) and repetitive behaviors or mental rituals (compulsions). Individuals with OCD may feel driven to perform these rituals to alleviate distress or prevent perceived harm, despite recognizing that the thoughts or behaviors are excessive or irrational.

Parkinson's Disease Dementia

Parkinson’s disease is a progressive neurological disorder that affects movement. It is characterized by tremors, rigidity, bradykinesia (slowness of movement), and postural instability. Parkinson’s disease results from the loss of dopamine-producing neurons in the brain, particularly in the substantia nigra region.

Rare Epilepsia (Epilepsy, eg LGS, Dravet, residual epilepsia)

Epilepsy is a neurological disorder characterized by recurrent seizures, which are sudden, uncontrolled electrical disturbances in the brain. While epilepsy is not rare, there are various rare forms of epilepsy that may have distinct genetic or structural causes, leading to unique seizure types and clinical presentations.

Post-Traumatic Stress Disorder (PTSD)

PTSD is a mental health condition that can develop after experiencing or witnessing a traumatic event. Symptoms may include flashbacks, nightmares, hypervigilance, avoidance of trauma-related stimuli, negative changes in mood and cognition, and emotional reactivity. PTSD can significantly impact an individual’s daily functioning and quality of life.

Neuropathic Pain

Neuropathic pain is a type of chronic pain caused by damage or dysfunction of the nervous system. It can result from conditions such as diabetes, multiple sclerosis, stroke, or traumatic injuries to the nervous system. Neuropathic pain is often described as burning, shooting, or electric shock-like sensations and can be challenging to manage with conventional pain medications.

The Multifaceted Impact of CNS Disorders

CNS disorders can have a profound impact on individuals, affecting various aspects of their physical health, cognitive functioning, emotional well-being, and overall quality of life. Below is an overview of the multifaceted impact of CNS disorder:

  1. Physical Functioning
    Many CNS disorders can impair physical functioning, leading to symptoms such as movement difficulties, muscle weakness, coordination problems, and sensory disturbances. These physical impairments can affect an individual’s ability to perform daily activities, maintain independence, and participate in work, school, or leisure activities.

  2. Cognitive Functioning
    CNS disorders can also affect cognitive functioning, including memory, attention, concentration, problem-solving, and decision-making abilities. Cognitive impairments can interfere with learning, communication, and social interactions, making it challenging to navigate various aspects of life.

  3. Emotional Well-being
    Living with a CNS disorder can be emotionally challenging, leading to feelings of frustration, sadness, anxiety, fear, or anger. Coping with physical limitations, cognitive changes, and uncertainty about the future can contribute to emotional distress and affect one’s overall mental health and well-being.

  4. Social Relationships
    CNS disorders can impact social relationships and interpersonal interactions. Individuals may experience difficulties with communication, social skills, and emotional regulation, which can strain relationships with family, friends, and colleagues. Social isolation and stigma associated with certain disorders may further exacerbate feelings of loneliness and alienation.

  5. Quality of Life
    The combined effects of physical, cognitive, and emotional challenges associated with CNS disorders can significantly impact an individual’s quality of life. Reduced mobility, cognitive impairment, chronic pain, and emotional distress can diminish overall well-being and satisfaction with life.

  6. Financial and Practical Considerations
    Managing a CNS disorder often requires medical treatment, rehabilitation, assistive devices, and supportive services, which can incur financial costs and logistical challenges for individuals and their families. These practical considerations can further add to the burden of living with a CNS disorder.

  7. Caregiver Burden
    CNS disorders not only affect individuals but also impact their caregivers and family members. Providing care and support for someone with a CNS disorder can be physically, emotionally, and financially demanding, leading to caregiver stress, burnout, and disruptions in their own lives.

Strategy

NEUROINNOVATECH’s strategy for intellectual property and clinical development revolves around forging partnerships with leading global institutions and experts in the domains of IP and CNS disorders. Through these collaborations, NEUROINNOVATECH aims to generate innovative intellectual property and advance its clinical initiatives, all while remaining closely aligned with the latest research and knowledge in these fields.

Business Model

NEUROINNOVATECH is committed to in-license and develop novel drugs designed to enhance efficacy in treating CNS symptoms, improve physical health, cognition, and social functioning, thereby enhancing overall quality of life for patients. Additionally, our novel drugs aim to improve financial independence and alleviate the burden on caregivers who provide support to those affected by CNS disorders.